Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles
Akshamal M. Gamage, Kai Sen Tan, Wharton O. Y. Chan, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 12, pp. e1009130-e1009130
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Carmen Gómez, Beatriz Perdiguero, Mariano Estéban
Vaccines (2021) Vol. 9, Iss. 3, pp. 243-243
Open Access | Times Cited: 268
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 167
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19
James P. Bridges, Eszter K. Vladar, Hua Huang, et al.
Thorax (2021) Vol. 77, Iss. 2, pp. 203-209
Open Access | Times Cited: 137
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications
Jasdeep Singh, Jasmine Samal, Vipul Kumar, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 439-439
Open Access | Times Cited: 120
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants
Cun Li, Jingjing Huang, Yifei Yu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 17
Open Access | Times Cited: 47
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
Catherine F. Hatton, Rachel A. Botting, María Emilia Dueñas, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 103
SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression
Artem Nemudryi, Anna Nemudraia, Tanner Wiegand, et al.
Cell Reports (2021) Vol. 35, Iss. 9, pp. 109197-109197
Open Access | Times Cited: 79
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
Enya Qing, Tom Kicmal, Binod Kumar, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 66
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
Fernando Gónzález‐Candelas, Marie-Anne Shaw, Tung Gia Phan, et al.
Infection Genetics and Evolution (2021) Vol. 92, pp. 104869-104869
Open Access | Times Cited: 65
SARS-CoV-2 Infection of Airway Epithelial Cells
Gwanghui Ryu, Hyun–Woo Shin
Immune Network (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 63
Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia
Sachiko Koyama, Kenji Kondo, Rumi Ueha, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8912-8912
Open Access | Times Cited: 63
SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs
Md Zobaer Hasan, Syful Islam, Kenichi Matsumoto, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 58
C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2–infected primary human airway epithelia
Wilfried Posch, Jonathan Vosper, Asma Noureen, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 147, Iss. 6, pp. 2083-2097.e6
Open Access | Times Cited: 57
Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8
Xin Wu, Tian Xia, Woo-Jin Shin, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 57
SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer
Kazuhiro Matsuoka, Nobuhiko Imahashi, Miki Ohno, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 3, pp. 101724-101724
Open Access | Times Cited: 44
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 44
Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants
Man Chun Chiu, Cun Li, Xiaojuan Liu, et al.
mBio (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 43
Choosing a cellular model to study SARS-CoV-2
Gabriel Augusto Pires de Souza, Marion Le Bideau, Céline Boschi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 43
SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study
Xuefeng Wang, Wenqi Wang, Tiecheng Wang, et al.
Journal of Virology (2023) Vol. 97, Iss. 3
Open Access | Times Cited: 23
Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 11
The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics
Anubama Rajan, Ashley Weaver, Gina M. Aloisio, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity
Alberto Gómez‐Carballa, Irene Rivero‐Calle, Jacobo Pardo‐Seco, et al.
Environmental Research (2022) Vol. 210, pp. 112890-112890
Open Access | Times Cited: 35
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
Chiara Ripamonti, Valeria Spadotto, Pietro Pozzi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1
Helen Stölting, Laury Baillon, Rebecca Frise, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 5, pp. 952-963
Open Access | Times Cited: 27
Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection In Vitro , despite Eliciting a Prolonged Antiviral Response
Akshamal M. Gamage, Kai Sen Tan, Wharton O. Y. Chan, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top